Based on the patient-derived glioma stem cells (GSCs) model, the transcription factor (SOX2)-oncomiR (miR-10b-5p)-TET2 axis was identified, which plays an important role in promoting GBM oncogenesis (45). This evidence concerns the gene TET2 and glioma.